Priority Date: 10.03.11 (EP 20110305262)

ATIP3 AND BIOLOGICALLY ACTIVE FRAGMENTS THEREOF FOR USE IN THE TREATMENT OF CANCER

  • Application ID: EP12707815
  • Status: APPLICATION DEEMED TO BE WITHDRAWN

Attorney

no operation time available
1069.27
2 offices
active in Legal Services

Specialization

This patent has the IPC combination C07 (ORGANIC CHEMISTRY) and C12 (BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING) is specialized in the combination C07 and C12. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 142 others are specialized in all of these IPC classes. For a similar patent, they might be a good choice.

Timeline

  • 10.03.2011 - Priority Date (EP 20110305262)
  • 13.09.2012 - Publication A1 (WO2012120151)
  • 15.01.2014 - Publication A1 (EP2683734)

IPC Classification